+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Circulating Tumor Cell (CTC) Diagnostics: Technologies and Global Markets- Product Image
Circulating Tumor Cell (CTC) Diagnostics: Technologies and Global Markets- Product Image
Sale

Circulating Tumor Cell (CTC) Diagnostics: Technologies and Global Markets

  • PDF Icon

    Report

  • 157 Pages
  • February 2022
  • Region: Global
  • BCC Research
  • ID: 4516194
UP TO OFF until Aug 31st 2033
Description Jump to:

Report Scope


The scope of this study involves clinical testing, prognostic and monitoring markets for CTCs in cancer. The report also includes the clinical research segment as well as currently approved CTC tests and their markets. The regulatory environment, current technologies, new technologies, cancer incidence, market projections and market share, along with the latest trends and new developments in this area, are included to support the clinical testing market.


  • Based on cancer type, the market for circulating tumor cells diagnostics is segmented into breast cancer, colorectal cancer and prostate cancer.
  • Based on technology, the market for circulating tumor cells diagnostics is segmented into CTC enrichment and detection, CTC direct detection and CTC analysis.
  • Based on application, the market for circulating tumor cells diagnostics is segmented into clinical/liquid biopsy and research.

The report discusses the qualitative and quantitative factors influencing market growth. Market drivers, restraints and opportunities are discussed in the report.

This report discusses some of the major drivers and restraints in the market for circulating tumor cells diagnostics, and it surveys the competitive landscape as well as the key players’ strategies and performances. The discussion is focused on the major market players, trends in product launches, collaborations, and mergers and acquisitions. The report also includes company profiles of major vendors that include a company overview, key product offerings, financial statistics and recent developments. The report provides insights on market shares and upcoming regional demand for circulating tumor cells diagnostics.

Some of the major market players discussed in the report are Qiagen N.V., Biocept Inc., Greiner Bio One International GmbH, Precision Medicine Group LLC and Menarini Silicon Biosystems. For market estimates, data have been provided for the 2020 as the base year, with forecasts for 2021 through 2026. Projected and forecasted revenue values are in constant U.S. dollars that have not been adjusted for inflation.


Report Includes


  • 24 data tables and 49 additional tables
  • An up-to-date review and analysis of the global markets for circulating tumor cell (CTC) diagnostics
  • Analyses of the global market trends, with data from 2019-2021, and projections of compound annual growth rates (CAGRs) through 2026
  • Highlights of the upcoming market opportunities in the CTC diagnostics industry, and areas of focus to forecast this market into various segments and sub-segments
  • Evaluation and forecast the global CTC diagnostics market size, forecasted growth trends, and corresponding market share analysis by cancer type, technology, application, and region
  • In-depth information concerning market drivers and challenges, latest technologies, breakthrough innovations, costs and benefits of CTC enrichment techniques, regulatory concerns, and clinical trials
  • Statistical information (facts and figures) on cancer incidence and prevalence, global cancer related deaths, and new cases of cancer by type in the United States
  • Review of recent industry trends, value chain analysis, competitive landscape, and COVID-19 implications within the marketplace
  • Descriptive company profiles of the leading global players, including Bio-Techne Corp., Biocept Inc., Greiner Bio-One International GmbH, Precision Medicine Group LLC, Menarini Silicon Biosystems, and Qiagen N.V.

Table of Contents

Chapter 1 Introduction
  • Study Background
  • Study Goals and Objectives
  • Reasons for Doing this Study
  • Scope of Report
  • What's New in this Update?
  • Information Sources
  • Methodology
  • Geographic Breakdown
  • Analyst's Credentials



Chapter 2 Summary and Highlights
Chapter 3 Market and Technology Background
  • Cancer
  • Recent Advances in Technology
  • Invasive Power
  • Circulating Tumor Cells
  • Phenotypic Characteristics
  • CTC Clusters
  • CTC Detection
  • Cancer Stem Cells (Cscs)
  • Circulating Tumor Cells - Potential Uses
  • Proliferative Activity
  • Epithelial Marker Genes on Circulating Tumor Cells
  • Circulating Tumor Cells and Stem Cell-Like Phenotype
  • CTCs and Primary Tumor Cells: a Comparison
  • Metastasis
  • Future Directions
  • Metastatic Development in Cancer Patients
  • Circulating Tumor Cell Migration
  • Circulating Tumor Cell Detection
  • Methods
  • Cellsearch Method
  • Epic Sciences Method
  • Maintrac
  • Iset Test
  • Challenges for Detection
  • Clinical Application of Circulating Tumor Dna
  • Circulating Tumor Cells as Predictor of Response to Therapy
  • Measurement of CTCs - Applications
  • Conclusion



Chapter 4 CTC Diagnostic Technologies
  • Finding Circulating Tumor Cells
  • Why CTCs?
  • Current CTC Detection and Isolation Methods
  • New Technologies for Detection
  • Cancer Prognosis
  • Nucleic Acid-Based Methods
  • Clinical Testing
  • Summary
  • New Emerging Technologies



Chapter 5 Impact of Covid-19 on the CTC Diagnostics Market
  • Overview
  • Covid-19 and Cancer Screening
  • Impact of Covid-19 on Company Revenues



Chapter 6 Market Dynamics
  • Market Drivers
  • Rising Incidence of Cancer Worldwide
  • Advantages Offered, by Noninvasivene Approach, by Circulating Tumor Cells
  • Advancements in Ngs and Immunofluorescence Technologies
  • Growing Awareness About the Novel Diagnostic Methods for Cancers
  • Market Restraints
  • High Costs of CTC Diagnostics
  • Rarity of CTCs in Blood Samples and Lack of Skilled Professionals for CTC Diagnostics
  • Market Opportunities
  • Circulating Tumor Cells as a Therapeutic Target
  • Competitive Landscape



Chapter 7 Market Breakdown by Cancer Type
  • Global Market for CTC Diagnostics by Cancer Type
  • Breast Cancer
  • Colorectal Cancer
  • Prostate Cancer



Chapter 8 Market Breakdown by Technology
  • Global Market for CTC Diagnostics by Technology
  • CTC Enrichment and Detection
  • CTC Direct Detection
  • CTC Analysis



Chapter 9 Market Breakdown by Application
  • Global Market for CTC Diagnostics by Application
  • Clinical/Liquid Biopsy
  • Research



Chapter 10 Market Breakdown by Region
  • Global Market for CTC Diagnostics by Region
  • North America
  • Europe
  • Asia-Pacific
  • Rest of World



Chapter 11 Company Profiles
  • Bio-Techne Corp. (Advanced Cell Diagnostics Inc.)
  • Biocept, Inc.
  • Biofluidica
  • Creatv Microtech Inc.
  • Fluxion Biosciences, Inc.
  • Greiner Bio-One International GmbH
  • Ikonisys, Inc.
  • Ivdiagnostics, Inc.
  • Menarini Silicon Biosystems (Formerly Veridex LLC)
  • Miltenyi Biotec
  • Precision Medicine Group LLC
  • Qiagen N.V.
  • Rarecells, Inc.
  • Screencell
  • Stemcell Technologies Inc.



Chapter 12 Appendix: List of Acronyms
List of Tables
Table A : New Additions to the Updated Version of the Report
Summary Table : Global Market for Circulating Tumor Cells (CTC) Diagnostics, by Cancer Type, Through 2026
Table 1 : Categories of Stem Cells
Table 2 : Product Categories
Table 3 : Key Characteristics of CTCs
Table 4 : Types of CTCs
Table 5 : Circulating Tumor Cells Features
Table 6 : Metastatic Cascade
Table 7 : EPCAM-Based Assays
Table 8 : Comparison of Different Liquid Biopsy Technologies
Table 9 : Potential Applications of CTC-Based Diagnostics
Table 10 : Clinical Relevance of CTC
Table 11 : CTC Enrichment Methods
Table 12 : Techniques Used for CTC Enrichment
Table 13 : Techniques Used for CTC Analysis
Table 14 : Enumeration Techniques
Table 15 : Functional Assays
Table 16 : Circulating Tumor Cells Technologies
Table 17 : Micro-Count Features: A New Technology
Table 18 : Ranking of Global Vendors of CTC Diagnostics, 2020
Table 19 : Global Market for CTC Diagnostics, by Cancer Type, Through 2026
Table 20 : Global Market for CTC Diagnostics for Breast Cancer, by Region, Through 2026
Table 21 : Global Market for CTC Diagnostics for Colorectal Cancer, by Region, Through 2026
Table 22 : Global Market for CTC Diagnostics for Prostate Cancer, by Region, Through 2026
Table 23 : Global Market for CTC Diagnostics, by Technology, Through 2026
Table 24 : CTC Enrichment Methods
Table 25 : Global Market for CTC Enrichment and Detection, by Region, Through 2026
Table 26 : Global Market for CTC Direct Detection, by Region, Through 2026
Table 27 : Global Market for CTC Analysis, by Region, Through 2026
Table 28 : Global Market for CTC Diagnostics, by Application, Through 2026
Table 29 : Global Market for CTC Diagnostics in Clinical/Liquid Biopsy Applications, by Region, Through 2026
Table 30 : Global Market for CTC Diagnostics in Research Applications, by Region, Through 2026
Table 31 : Global Market for CTC Diagnostics, by Region, Through 2026
Table 32 : North American Market for CTC Diagnostics, by Cancer Type, Through 2026
Table 33 : North American Market for CTC Diagnostics, by Country, Through 2026
Table 34 : Estimated Number of New Cases and Age-Standardized Incidence Rates for Cancers in Canada, by Sex, 2020
Table 35 : European Market for CTC Diagnostics, by Cancer Type, Through 2026
Table 36 : European Market for CTC Diagnostics, by Country, Through 2026
Table 37 : Asia-Pacific Market for CTC Diagnostics, by Cancer Type, Through 2026
Table 38 : Asia-Pacific Market for CTC Diagnostics, by Country, Through 2026
Table 39 : Age-Standardized Cancer Incidence and Mortality Rates in China, by Gender, 2018
Table 40 : Rest of World Market for CTC Diagnostics, by Cancer Type, Through 2026
Table 41 : Bio-Techne Corp. (Advanced Cell Diagnostics Inc.): R&D Expenditures, 2018-2020
Table 42 : Bio-Techne Corp. (Advanced Cell Diagnostics Inc.): Products Offered
Table 43 : Bio-Techne Corp. (Advanced Cell Diagnostics Inc.): Recent Developments
Table 44 : Biocept, Inc.: R&D Expenditures, 2019 and 2020
Table 45 : Biocept, Inc.: Solutions/Services Offered
Table 46 : Biocept, Inc.: Recent Developments
Table 47 : BioFluidica: Solutions/Services Offered
Table 48 : BioFluidica: Recent Developments
Table 49 : Creatv MicroTech Inc.: Products Offered
Table 50 : Creatv MicroTech Inc: Recent Developments
Table 51 : Fluxion Biosciences, Inc.: Solutions/Services Offered
Table 52 : Fluxion Biosciences, Inc.: Recent Developments
Table 53 : Greiner Bio-One International GmbH: Products Offered
Table 54 : Ikonisys, Inc.: Products Offered
Table 55 : Ikonisys, Inc.: Recent Developments
Table 56 : IVDiagnostics, Inc.: Products/Services Offered
Table 57 : IVDiagnostics, Inc.: Recent Developments
Table 58 : Menarini Silicon Biosystems: Products Offered
Table 59 : Menarini Silicon Biosystems: Recent Developments
Table 60 : Miltenyi Biotec: Products Offered
Table 61 : Precision Medicine Group LLC: Products Offered
Table 62 : Precision Medicine Group LLC: Recent Developments
Table 63 : Qiagen: Products Offered
Table 64 : Qiagen: Recent Developments
Table 65 : Rarecells, Inc.: Products Offered
Table 66 : Rarecells, Inc.: Recent Developments
Table 67 : ScreenCell: Products Offered
Table 68 : ScreenCell: Recent Developments, 2021
Table 69 : STEMCELL Technologies Inc.: Products/Services Offered
Table 70 : STEMCELL Technologies Inc.: Recent Developments
Table 71 : Commonly Used Acronyms in the Market for CTC Diagnostics
List of Figures
Summary Figure : Global Market Shares of Circulating Tumor Cells (CTC) Diagnostics, by Cancer Type, 2020
Figure 1 : Global Market Shares of CTC Diagnostics, by Cancer Type, 2020
Figure 2 : Global Market for CTC Diagnostics for Breast Cancer, 2019-2026
Figure 3 : Global Market for CTC Diagnostics for Breast Cancer, by Region, 2019-2026
Figure 4 : Global Market for CTC Diagnostics for Colorectal Cancer, 2019-2026
Figure 5 : Global Market for CTC Diagnostics for Colorectal Cancer, by Region, 2019-2026
Figure 6 : Global Market for CTC Diagnostics for Prostate Cancer, 2019-2026
Figure 7 : Global Market for CTC Diagnostics for Prostate Cancer, by Region, 2019-2026
Figure 8 : Global Market Shares of CTC Diagnostics, by Technology, 2020
Figure 9 : Global Market for CTC Enrichment and Detection, 2019-2026
Figure 10 : Global Market for CTC Enrichment and Detection, by Region, 2019-2026
Figure 11 : Global Market for CTC Direct Detection, 2019-2026
Figure 12 : Global Market for CTC Direct Detection, by Region, 2019-2026
Figure 13 : Global Market for CTC Analysis, 2019-2026
Figure 14 : Global Market for CTC Analysis, by Region, 2019-2026
Figure 15 : Global Market Shares of CTC Diagnostics, by Application, 2020
Figure 16 : Global Market for CTC Diagnostics in Clinical/Liquid Biopsy Applications, 2019-2026
Figure 17 : Global Market for CTC Diagnostics in Clinical/Liquid Biopsy Applications, by Region, 2019-2026
Figure 18 : Global Market for CTC Diagnostics in Research Applications, 2019-2026
Figure 19 : Global Market for CTC Diagnostics in Research Applications, by Region, 2019-2026
Figure 20 : Global Market for CTC Diagnostics, by Region, 2019-2026
Figure 21 : Global Market Shares of CTC Diagnostics, by Region, 2020
Figure 22 : North American Market Shares of CTC Diagnostics, by Cancer Type, 2020
Figure 23 : North American Market Shares of CTC Diagnostics, by Country, 2020
Figure 24 : U.S. Market for CTC Diagnostics, 2019-2026
Figure 25 : Canadian Market for CTC Diagnostics, 2019-2026
Figure 26 : European Market Shares of CTC Diagnostics, by Cancer Type, 2020
Figure 27 : European Market Shares of CTC Diagnostics, by Country, 2020
Figure 28 : German Market for CTC Diagnostics, 2019-2026
Figure 29 : French Market for CTC Diagnostics, 2019-2026
Figure 30 : U.K. Market for CTC Diagnostics, 2019-2026
Figure 31 : Italian Market for CTC Diagnostics, 2019-2026
Figure 32 : Spanish Market for CTC Diagnostics, 2019-2026
Figure 33 : Rest of European Market for CTC Diagnostics, 2019-2026
Figure 34 : Asia-Pacific Market Shares of CTC Diagnostics, by Cancer Type, 2020
Figure 35 : Asia-Pacific Market Shares of CTC Diagnostics, by Country, 2020
Figure 36 : Chinese Market for CTC Diagnostics, 2019-2026
Figure 37 : Indian Market for CTC Diagnostics, 2019-2026
Figure 38 : Japanese Market for CTC Diagnostics, 2019-2026
Figure 39 : Australian Market for CTC Diagnostics, 2019-2026
Figure 40 : Rest of Asia-Pacific Market for CTC Diagnostics, 2019-2026
Figure 41 : Rest of World Market Shares of CTC Diagnostics, by Cancer Type, 2020
Figure 42 : Bio-Techne Corp. (Advanced Cell Diagnostics Inc.): Net Revenue, 2016-2020
Figure 43 : Bio-Techne Corp. (Advanced Cell Diagnostics Inc.): Revenue Share, by Business Segment, 2020
Figure 44 : Bio-Techne Corp. (Advanced Cell Diagnostics Inc.): Revenue Share, by Region, 2020
Figure 45 : Biocept, Inc.: Net Revenue, 2016-2020
Figure 46 : Greiner Bio-One International GmbH: Net Revenue, 2016-2020
Figure 47 : Greiner Bio-One International GmbH: Revenue Share, by Business Segment, 2020
Figure 48 : Greiner Bio-One International GmbH: Revenue Share, by Region, 2020
Figure 49 : Qiagen: Net Revenue, 2016-2020
Figure 50 : Qiagen: Revenue Share, by Business Segment, 2020
Figure 51 : Qiagen: Revenue Share, by Region, 2020

Samples

Loading
LOADING...

Executive Summary

By cancer type, the global market for circulating tumor cells diagnostics has been segmented into breast cancer, colorectal cancer and prostate cancer. The fast growth rate of the colorectal cancer segment is attributed to rapid rise in the incidence of colorectal cancer, especially young adults. The growing prevalence of cancer, as circulating tumor cells find their applications in the diagnosis of cancer and precision management; advancements in technologies such as NGS and immunofluorescence; and growing awareness about the novel diagnostic methods for cancers are all major factors that will boost market growth.

Reasons for Doing this Study


This study was conducted to provide detailed information regarding new developments, prognostic and clinical research testing for circulating tumor cells. There is an increasing need for new and innovative technologies in this area. This industry is experiencing tremendous growth; the use of new prognostic technologies based on circulating tumor cells has increased in the past few years.

This study will increase awareness of current and emerging technologies and practices for cancer and cancer research, especially for prostate, breast and colorectal cancers.

Companies Mentioned

  • Bio-Techne Corp. (Advanced Cell Diagnostics Inc.)
  • Biocept, Inc.
  • Biofluidica
  • Creatv Microtech Inc.
  • Fluxion Biosciences, Inc.
  • Greiner Bio-One International GmbH
  • Ikonisys, Inc.
  • Ivdiagnostics, Inc.
  • Menarini Silicon Biosystems (Formerly Veridex LLC)
  • Miltenyi Biotec
  • Precision Medicine Group LLC
  • Qiagen N.V.
  • Rarecells, Inc.
  • Screencell
  • Stemcell Technologies Inc.

Related Topics

Related Reports

Circulating Tumor Cell (CTC) Diagnostics: Global Strategic Business Report - Product Image

Circulating Tumor Cell (CTC) Diagnostics: Global Strategic Business Report

  • Report
  • 196 Pages
  • Global
From
Circulating Tumor Cells Global Market Report 2024 - Product Image

Circulating Tumor Cells Global Market Report 2024

  • Report
  • 200 Pages
  • Global
From
Global Circulating Tumor Cells (CTC) Market (2023-2028) Competitive Analysis, Impact of Covid-19, Ansoff Analysis - Product Image

Global Circulating Tumor Cells (CTC) Market (2023-2028) Competitive Analysis, Impact of Covid-19, Ansoff Analysis

  • Report
  • 204 Pages
  • Global
From
Circulating Tumor Cells Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F - Product Image

Circulating Tumor Cells Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F

  • Report
  • 182 Pages
  • Global
From
Global Circulating Tumor Cell Market by Specimen (Blood, Bone Marrow), Technology (CTC Analysis, CTC Detection & Enrichment Methods, CTC Direct Detection Methods), Product, Application - Forecast 2024-2030 - Product Image

Global Circulating Tumor Cell Market by Specimen (Blood, Bone Marrow), Technology (CTC Analysis, CTC Detection & Enrichment Methods, CTC Direct Detection Methods), Product, Application - Forecast 2024-2030

  • Report
  • 193 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.